← FDA DRUG APPROVALS

FDA ANDA · ANDA090600

GLYCOLAX

Sponsor: LANNETT CO INC

APPLICATION
ANDA090600
TYPE
ANDA
ORIGINAL APPROVAL
2009-10-06
LATEST ACTION
2012-06-07
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued

Products

GLYCOLAXDiscontinued
POLYETHYLENE GLYCOL 3350 17GM/PACKET · FOR SOLUTION · ORAL
GLYCOLAXDiscontinued
POLYETHYLENE GLYCOL 3350 17GM/SCOOPFUL · FOR SOLUTION · ORAL

Approval history

2012-06-07Labeling · Supplement 7AP
2011-10-21Manufacturing (CMC) · Supplement 4AP
2010-03-08Labeling · Supplement 1AP
2009-10-06OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →